Formulary
Ocular lubricants under normal circumstances should be purchased OTC.
For treatment of filamentary keratitis only| Carmellose |
|
Formulary
|
Multidose / unit dose preservative free eye drops 0.5%, 1% Preservative free preparation only to be used for those patients with documented allergies to preservatives. |
|
| Ciclosporin 0.1% eye drops |
|
Formulary
|
Unit dose eye drops emulsion 0.1% (Ikervis) - For adult patients Unit dose eye drops emulsion 0.1% (Verkazia) - For children and adolescents |
 LSCMMG: Ciclosporin (Verkazia) eye drops NMR NICE TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears |
|
| Hypromellose |
|
Formulary
|
Eye drops 0.3% Preservative free preparation only to be used for those patients with documented allergies to preservatives. |
|
|
| Polyvinyl Alcohol |
|
Formulary
|
Eye drops 1.4% Preservative free preparation only to be used for those patients with documented allergies to preservatives. |
|
|
Eyedrops Sodium hyaluronate 0.1%, co-enzyme Q10 0.1%, vitamin E 0.5% (VisuXL®) short term use (max 1 month).| White soft paraffin / Vitamin A 250IU/g Hylo-night® |
|
Formulary
|
Eye ointment preservative free 2nd line to Hydramed Night |
|
|
Links
- LSCMMG: Ciclosporin (Verkazia) eye drops NMR
- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy
- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears
- TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears